Market Price

62.65 

1.37 -3.0%

as of Jul 10 '20

52 Week Range:

52.04 77.03


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services. The company's Retail/LTC segment sells prescription drugs and general merchandise, such as over-the-counter drugs, beauty products, cosmetics, and personal care products, as well as provides health care services through its MinuteClinic walk-in medical clinics. Its Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management, Medicare plans, PDPs, Medicaid health care management services, workers' compensation administrative services, and health information technology products and services. The company's customers include employers, insurance companies, unions, government employee groups, health plans, Medicare Part D prescription drug plans, Medicaid managed care plans, plans offered on public health insurance exchanges and private health insurance exchanges, other sponsors of health benefit plans, individuals, college students, workers, labor groups, and expatriates. As of December 31, 2018, it had approximately 40 leased on-site pharmacies, 25 leased retail specialty pharmacy stores, 20 specialty mail order pharmacies, and 90 branches for infusion and enteral services; and 9,900 retail locations and 1,100 MinuteClinic locations, as well as operated an online retail pharmacy Websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Equity (BVPS) 25.71
27.66
28.88
30.63
32.66
33.42
33.76
33.88
34.38
28.28
48.09
growth rate 7.6% 4.4% 6.1% 6.6% 2.3% 1.0% 0.4% 1.5% -17.7% 70.1%
Earnings BIT 5,910.00
5,630.00
5,750.00
6,320.00
7,530.00
8,824.00
9,695.00
10,576.00
9,770.00
10,051.00
11,818.00
growth rate -4.7% 2.1% 9.9% 19.2% 17.2% 9.9% 9.1% -7.6% 2.9% 17.6%
Avg.PE 12.58
13.91
15.75
15.95
19.08
25.92
21.63
16.83
14.53
20.37
20.93
growth rate 10.6% 13.2% 1.3% 19.6% 35.9% -16.6% -22.2% -13.7% 40.2% 2.8%
ROA 6.03
5.54
5.46
5.94
6.68
6.37
6.24
5.65
6.99
-0.41
3.17
growth rate -8.1% -1.4% 8.8% 12.5% -4.6% -2.0% -9.5% 23.7% -100.0% 100.0%
ROE 10.54
9.33
9.14
10.24
12.14
12.24
13.94
14.37
17.77
-1.24
10.87
growth rate -11.5% -2.0% 12.0% 18.6% 0.8% 13.9% 3.1% 23.7% -100.0% 100.0%
ROIC 8.65
7.93
7.96
8.83
9.92
9.79
9.94
9.25
11.56
1.34
6.24
growth rate -8.3% 0.4% 10.9% 12.3% -1.3% 1.5% -6.9% 25.0% -88.4% 365.7%
Cur. Ratio 1.43
1.60
1.56
1.44
1.64
1.37
1.31
1.18
1.01
1.03
0.94
growth rate 11.9% -2.5% -7.7% 13.9% -16.5% -4.4% -9.9% -14.4% 2.0% -8.7%
Quick Ratio 0.53
0.57
0.62
0.57
0.84
0.64
0.62
0.60
0.48
0.55
0.52
growth rate 7.6% 8.8% -8.1% 47.4% -23.8% -3.1% -3.2% -20.0% 14.6% -5.5%
Leverage 1.72
1.65
1.70
1.75
1.89
1.96
2.52
2.56
2.52
3.37
3.48
growth rate -4.1% 3.0% 2.9% 8.0% 3.7% 28.6% 1.6% -1.6% 33.7% 3.3%
Balance Sheet Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Acct.Receivable 5,457.00
4,925.00
6,550.00
7,172.00
9,631.00
9,687.00
11,888.00
12,164.00
13,181.00
17,631.00
19,617.00
growth rate -9.8% 33.0% 9.5% 34.3% 0.6% 22.7% 2.3% 8.4% 33.8% 11.3%
Acct.Payable 7,663.00
9,481.00
10,316.00
6,547.00
7,490.00
7,946.00
8,863.00
8,925.00
10,492.00
growth rate 23.7% 8.8% -36.5% 14.4% 6.1% 11.5% 0.7% 17.6%
Cur.Assets 17,537.00
17,706.00
18,594.00
20,161.00
25,325.00
25,983.00
29,158.00
31,042.00
31,229.00
45,243.00
50,302.00
growth rate 1.0% 5.0% 8.4% 25.6% 2.6% 12.2% 6.5% 0.6% 44.9% 11.2%
Total Assets 61,641.00
62,169.00
64,543.00
66,221.00
71,526.00
74,187.00
92,437.00
94,462.00
95,131.00
196,456.00
222,449.00
growth rate 0.9% 3.8% 2.6% 8.0% 3.7% 24.6% 2.2% 0.7% 106.5% 13.2%
Cash 1,086.00
1,427.00
1,413.00
1,375.00
4,089.00
2,481.00
2,459.00
3,371.00
1,696.00
4,059.00
5,683.00
growth rate 31.4% -1.0% -2.7% 197.4% -39.3% -0.9% 37.1% -49.7% 139.3% 40.0%
Inventory 10,343.00
10,695.00
10,046.00
11,032.00
11,045.00
11,930.00
14,001.00
14,760.00
15,296.00
16,450.00
17,516.00
growth rate 3.4% -6.1% 9.8% 0.1% 8.0% 17.4% 5.4% 3.6% 7.5% 6.5%
Cur.Liabilities 12,300.00
11,070.00
11,956.00
14,150.00
15,425.00
19,027.00
23,169.00
26,250.00
30,648.00
44,009.00
53,303.00
growth rate -10.0% 8.0% 18.4% 9.0% 23.4% 21.8% 13.3% 16.8% 43.6% 21.1%
Liabilities 25,873.00
24,469.00
26,462.00
28,568.00
33,588.00
36,224.00
55,195.00
57,628.00
57,436.00
137,913.00
158,279.00
growth rate -5.4% 8.1% 8.0% 17.6% 7.9% 52.4% 4.4% -0.3% 140.1% 14.8%
LT Debt 8,756.00
8,652.00
9,208.00
9,133.00
12,841.00
11,630.00
26,267.00
25,615.00
21,511.00
70,802.00
63,918.00
growth rate -1.2% 6.4% -0.8% 40.6% -9.4% 125.9% -2.5% -16.0% 229.1% -9.7%
Equity 35,768.00
37,700.00
38,051.00
37,653.00
37,938.00
37,958.00
37,196.00
36,830.00
37,691.00
58,225.00
63,864.00
growth rate 5.4% 0.9% -1.1% 0.8% 0.1% -2.0% -1.0% 2.3% 54.5% 9.7%
Common Shares 1,450.00
1,377.00
1,347.00
1,280.00
1,226.00
1,169.00
1,126.00
1,079.00
1,024.00
1,044.00
1,305.00
growth rate -5.0% -2.2% -5.0% -4.2% -4.7% -3.7% -4.2% -5.1% 2.0% 25.0%
Cash Flow Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Capital Expenditures 2,525.00
1,971.00
1,872.00
2,030.00
1,984.00
2,136.00
2,367.00
2,224.00
1,918.00
2,037.00
2,457.00
growth rate -21.9% -5.0% 8.4% -2.3% 7.7% 10.8% -6.0% -13.8% 6.2% 20.6%
Cash Dividends 439.00
479.00
674.00
829.00
1,097.00
1,288.00
1,576.00
1,840.00
2,049.00
2,038.00
2,603.00
growth rate 9.1% 40.7% 23.0% 32.3% 17.4% 22.4% 16.8% 11.4% -0.5% 27.7%
Cash From OA 4,035.00
4,779.00
5,856.00
6,671.00
5,783.00
8,137.00
8,539.00
10,141.00
8,007.00
8,865.00
12,848.00
growth rate 18.4% 22.5% 13.9% -13.3% 40.7% 4.9% 18.8% -21.0% 10.7% 44.9%
FCF per Share 1.03
2.01
3.69
3.63
3.17
3.52
5.35
8.28
7.87
4.22
8.12
growth rate 95.2% 83.6% -1.6% -12.7% 11.0% 52.0% 54.8% -5.0% -46.4% 92.4%
Sale Purchase of Stock -2,570.00
-3,520.00
-3,476.00
421.00
362.00
296.00
329.00
growth rate 0.0% 0.0% 100.0% -14.0% -18.2% 11.2%
FCF 1,487.00
2,774.00
3,984.00
4,641.00
3,799.00
6,001.00
6,045.00
7,845.00
6,089.00
6,828.00
10,391.00
growth rate 86.6% 43.6% 16.5% -18.1% 58.0% 0.7% 29.8% -22.4% 12.1% 52.2%
Income Statement Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19
Sales 98,215.00
95,778.00
107,080.00
123,120.00
126,761.00
139,367.00
153,290.00
177,526.00
184,765.00
193,919.00
255,765.00
growth rate -2.5% 11.8% 15.0% 3.0% 9.9% 10.0% 15.8% 4.1% 5.0% 31.9%
Op.Income 6,425.00
6,137.00
3,489.00
3,869.00
4,600.00
8,824.00
9,695.00
10,576.00
9,770.00
10,051.00
11,818.00
growth rate -4.5% -43.2% 10.9% 18.9% 91.8% 9.9% 9.1% -7.6% 2.9% 17.6%
IBT 5,900.00
5,601.00
5,747.00
6,305.00
7,528.00
7,678.00
8,616.00
8,637.00
8,268.00
1,406.00
8,997.00
growth rate -5.1% 2.6% 9.7% 19.4% 2.0% 12.2% 0.2% -4.3% -83.0% 539.9%
Net Income 3,696.00
3,427.00
3,489.00
3,869.00
4,600.00
4,644.00
5,237.00
5,317.00
6,622.00
-594.00
6,634.00
growth rate -7.3% 1.8% 10.9% 18.9% 1.0% 12.8% 1.5% 24.5% -100.0% 100.0%
EPS 2.55
2.49
2.57
3.02
3.74
3.96
4.63
4.90
6.44
-0.57
5.08
growth rate -2.4% 3.2% 17.5% 23.8% 5.9% 16.9% 5.8% 31.4% -100.0% 100.0%
Gross Profit 20,358.00
20,219.00
20,562.00
22,488.00
23,783.00
25,367.00
26,528.00
28,860.00
28,507.00
30,878.00
44,517.00
growth rate -0.7% 1.7% 9.4% 5.8% 6.7% 4.6% 8.8% -1.2% 8.3% 44.2%

Quarterly Statements

Item Name Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Earnings BIT 2,724.00
3,145.00
2,872.00
3,077.00
3,365.00
growth rate 15.5% -8.7% 7.1% 9.4%
Balance Sheet Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Acct.Receivable 19,509.00
18,174.00
19,789.00
19,617.00
23,037.00
growth rate -6.8% 8.9% -0.9% 17.4%
Acct.Payable 8,290.00
9,160.00
9,442.00
10,492.00
10,223.00
growth rate 10.5% 3.1% 11.1% -2.6%
Cur.Assets 47,857.00
46,901.00
48,185.00
50,302.00
58,958.00
growth rate -2.0% 2.7% 4.4% 17.2%
Total Assets 219,768.00
218,904.00
220,113.00
222,449.00
230,639.00
growth rate -0.4% 0.6% 1.1% 3.7%
Cash 5,896.00
6,063.00
5,193.00
5,683.00
10,081.00
growth rate 2.8% -14.4% 9.4% 77.4%
Inventory 15,448.00
15,511.00
16,028.00
17,516.00
16,976.00
growth rate 0.4% 3.3% 9.3% -3.1%
Cur.Liabilities 50,631.00
49,376.00
52,544.00
53,303.00
59,560.00
growth rate -2.5% 6.4% 1.4% 11.7%
Liabilities 159,762.00
157,305.00
157,180.00
158,279.00
165,165.00
growth rate -1.5% -0.1% 0.7% 4.4%
LT Debt 67,353.00
66,382.00
63,615.00
63,918.00
64,816.00
growth rate -1.4% -4.2% 0.5% 1.4%
Equity 59,686.00
61,282.00
62,614.00
63,864.00
65,140.00
growth rate 2.7% 2.2% 2.0% 2.0%
Common Shares 17.00
17.00
17.00
17.00
17.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Capital Expenditures 716.00
573.00
601.00
567.00
742.00
growth rate -20.0% 4.9% -5.7% 30.9%
Cash Dividends 649.00
657.00
646.00
651.00
652.00
growth rate 1.2% -1.7% 0.8% 0.2%
Cash From OA 1,948.00
5,338.00
2,928.00
2,634.00
3,305.00
growth rate 174.0% -45.2% -10.0% 25.5%
Sale Purchase of Stock
growth rate
FCF 1,232.00
4,765.00
2,327.00
2,067.00
2,563.00
growth rate 286.8% -51.2% -11.2% 24.0%
Income Statement Mar '19 Jun '19 Sep '19 Dec '19 Mar '20
Sales 61,397.00
63,138.00
64,547.00
66,683.00
66,593.00
growth rate 2.8% 2.2% 3.3% -0.1%
Op.Income 2,724.00
3,145.00
2,872.00
3,077.00
3,365.00
growth rate 15.5% -8.7% 7.1% 9.4%
IBT 1,939.00
2,591.00
2,133.00
2,334.00
2,779.00
growth rate 33.6% -17.7% 9.4% 19.1%
Net Income 1,421.00
1,936.00
1,530.00
1,747.00
2,007.00
growth rate 36.2% -21.0% 14.2% 14.9%
EPS
growth rate
Gross Profit 10,691.00
11,081.00
11,260.00
11,485.00
11,859.00
growth rate 3.7% 1.6% 2.0% 3.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (76.54)

YOY Growth Grade:

C (52.60)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 20.93 17.65 10.42
EPS / Growth 10.9% 3.55 6.1%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 12.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 6.1% 9.7% 9.7%
Future PE 10.42 16.92 16.92
Future EPS 6.44 8.96 8.96
Value Price
MOS %
16.59
-73.5%
37.47
-40.2%
37.47
-40.2%
MOS Price 8.30 18.73 18.73
IRT 11.80 10.15 10.15

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.